1. Home
  2. ROCK vs IVA Comparison

ROCK vs IVA Comparison

Compare ROCK & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gibraltar Industries Inc.

ROCK

Gibraltar Industries Inc.

HOLD

Current Price

$53.91

Market Cap

1.5B

Sector

N/A

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.88

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROCK
IVA
Founded
1972
2011
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
1993
2020

Fundamental Metrics

Financial Performance
Metric
ROCK
IVA
Price
$53.91
$5.88
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$16.20
AVG Volume (30 Days)
426.4K
616.4K
Earning Date
02-19-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$1,383,811,000.00
$19,929,536.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.20
N/A
P/E Ratio
$397.95
N/A
Revenue Growth
23.49
N/A
52 Week Low
$42.86
$2.23
52 Week High
$75.08
$7.98

Technical Indicators

Market Signals
Indicator
ROCK
IVA
Relative Strength Index (RSI) 54.08 49.10
Support Level $51.84 $5.89
Resistance Level $53.77 $6.26
Average True Range (ATR) 2.22 0.35
MACD 0.07 -0.16
Stochastic Oscillator 75.52 6.33

Price Performance

Historical Comparison
ROCK
IVA

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: